Qiming Venture Partners Leads $42M New Round In Chinese Biotech Start-Up

Abbisko Therapeutics, a Chinese biotech start-up that develops drugs for cancer treatment, announced on Friday that it has raised US$42 million in a new round of financing led by Chinese venture capital firm Qiming Venture Partners.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

LEAVE A REPLY